Login
+44 203 371 1100
Login
+44 203 371 1100
Credit Sector:- Health Care
Country:- United States
Bond Document:- https://www.bondpdf.com
In order to view the complete data, please login here
| Announcement Date | CA Type | CA Impact | CA Event | ISIN |
|---|---|---|---|---|
| 13-Feb-2019 | Asset Acquisition | - | - | US00214WAE12 |
| Charles River Laboratories International, Inc. announced today that it has signed a binding offer to acquire Citoxlab | ||||
| 03-Apr-2018 | Acquisition | Acquired Name | MPI Research, Inc. | US00214WAE12 |
| Charles River Laboratories International, Inc. announced today that it has completed the previously announced acquisition of MPI Research, Inc. | ||||
| 03-Apr-2018 | New Bond | - | - | US159864AC13 |
| Charles River Laboratories International, Inc. has issued USD 500MM, 5.5% fixed rate bond due 01-Apr-2026. | ||||
| 03-Apr-2018 | Propose Merger | Target Name | ACP Mountain Holdings, Inc. | US00214WAE12 |
| Charles River Laboratories International, Inc. today announced that it has agreed to merge with ACP Mountain Holdings, Inc. | ||||
| 11-Jan-2018 | Acquisition | Acquired Name | KWS BioTest Ltd. | US00214WAE12 |
| Charles River Laboratories International, Inc. announced today that it has acquired KWS BioTest Ltd. | ||||
All of the financial data available on this page is sourced from FactEntry.